Open Payments

Aultman Hospital

Type
Teaching hospital
Where
Canton, OH
Medicare CCN
360084
Received
$883,198 in 117 records, 2020 ($33,026 general, $850,172 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment23$33,026
2020Research payment94$850,172

By company

CompanyRecordsAmountYears
GlaxoSmithKline, LLC.15$289,4622020
Amgen Inc.6$169,6152020
Novartis Pharmaceuticals Corporation2$151,4612020
Boston Scientific Corporation17$71,6872020
Eli Lilly and Company2$46,7682020
Kowa Research Institute, Inc.13$37,1862020
American Regent6$30,9382020
PFIZER INC.10$22,4772020
AstraZeneca UK Limited1$20,0222020
CSL Behring11$14,9382020
AstraZeneca Pharmaceuticals LP4$14,1492020
GE HEALTHCARE1$3,0232020
Medtronic Vascular, Inc.1$2,5952020
Esperion Therapeutics, Inc.6$2,4122020
Abbott Laboratories3$2,0252020
Stryker Corporation1$1,8582020
Aesculap, Inc.1$9492020
Sterilmed, Inc.12$6532020
E.R. Squibb & Sons, L.L.C.1$5502020
Siemens Medical Solutions USA, Inc.1$2872020
Olympus America Inc.1$842020
Masimo Corporation1$382020
Zimmer Biomet Holdings, Inc.1$122020

By nature of payment

NatureRecordsAmount
Research payment94$850,172
Compensation for services other than consulting, including serving as faculty or as a speaker at a v14$23,699
Space rental or facility fees (teaching hospital only)2$3,500
Gift3$2,892
Grant1$2,595
Charitable Contribution1$287
Education1$38
Food and Beverage1$12

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Stryker Corporation$1,858GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31AstraZeneca Pharmaceuticals LP$550Research paymentIn-kind items and servicesStudy of 1st Line Therapy Study of MEDI4736 With Tremelimumab Versus SoC in Non Small Cell Lung Cancer NSCLC NEPTUNE2020
2020-12-31Siemens Medical Solutions USA, Inc.$287Charitable ContributionIn-kind items and services2020
2020-12-31Masimo Corporation$38EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-23Esperion Therapeutics, Inc.$202Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-12-23Esperion Therapeutics, Inc.$202Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-12-21Boston Scientific Corporation$400Research paymentCash or cash equivalentResonate Device, TachyPREEMPT HF2020
2020-12-18Sterilmed, Inc.$34Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-12-15GlaxoSmithKline, LLC.$2,763Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-12-10Aesculap, Inc.$949GiftCash or cash equivalent2020
2020-12-01Kowa Research Institute, Inc.$1,290Research paymentCash or cash equivalent DrugK-877-3022020
2020-11-24Amgen Inc.$15,322Research paymentCash or cash equivalentRepatha Biological, CardiologyFOURIER OLE (Ph 4)2020
2020-11-24GlaxoSmithKline, LLC.$5,673Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-11-23Amgen Inc.$16,304Research paymentIn-kind items and servicesRepatha Biological, CardiologyFOURIER OLE (Ph 4)2020
2020-11-16Esperion Therapeutics, Inc.$202Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-11-16Boston Scientific Corporation$125Research paymentCash or cash equivalentResonate Device, TachyPREEMPT HF2020
2020-11-12Sterilmed, Inc.$6Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-11-03Kowa Research Institute, Inc.$832Research paymentCash or cash equivalent DrugK-877-3022020
2020-11-02Esperion Therapeutics, Inc.$602Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-11-02Boston Scientific Corporation$516Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2020
2020-10-22Medtronic Vascular, Inc.$2,595GrantIn-kind items and servicesIN.PACT AV Device, Drug-Coated Balloons2020
2020-10-20GlaxoSmithKline, LLC.$4,895Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-10-19Boston Scientific Corporation$1,544Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-10-19Boston Scientific Corporation$200Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-10-15American Regent$3,617Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-10-07Sterilmed, Inc.$38Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-10-05Boston Scientific Corporation$56,917Research paymentCash or cash equivalentResonate Device, TachyPREEMPT HF2020
2020-10-01Kowa Research Institute, Inc.$2,475Research paymentCash or cash equivalent DrugK-877-3022020
2020-09-23Esperion Therapeutics, Inc.$602Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-09-23Esperion Therapeutics, Inc.$602Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2020
2020-09-21Boston Scientific Corporation$1,080Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-09-15GlaxoSmithKline, LLC.$889Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-09-10CSL Behring$764Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-09-10CSL Behring$50Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-09-08Boston Scientific Corporation$263Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2020
2020-09-03Sterilmed, Inc.$35Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-08-26PFIZER INC.$2,280Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-08-26Kowa Research Institute, Inc.$952Research paymentCash or cash equivalent DrugK-877-3022020
2020-08-26PFIZER INC.$120Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-08-26CSL Behring$67Research paymentIn-kind items and servicesA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-08-21Amgen Inc.$925Research paymentIn-kind items and servicesNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC.2020
2020-08-18GlaxoSmithKline, LLC.$5,324Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-08-18Kowa Research Institute, Inc.$386Research paymentCash or cash equivalent DrugK-877-3022020
2020-08-17Boston Scientific Corporation$440Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-08-05Sterilmed, Inc.$51Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-08-05Sterilmed, Inc.$7Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-08-04GlaxoSmithKline, LLC.$47,223Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-08-04GlaxoSmithKline, LLC.$2,572Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-07-28CSL Behring$1,027Research paymentIn-kind items and servicesA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-07-27Kowa Research Institute, Inc.$2,641Research paymentCash or cash equivalent DrugK-877-3022020
2020-07-23AstraZeneca UK Limited$20,022Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-07-21GlaxoSmithKline, LLC.$5,803Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-07-20PFIZER INC.$19Research paymentIn-kind items and servicesA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-07-12AstraZeneca Pharmaceuticals LP$1,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentIMFINZI Drug, Oncology2020
2020-07-09AstraZeneca Pharmaceuticals LP$2,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentLYNPARZA Drug, Oncology2020
2020-07-08American Regent$10,173Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-07-07GlaxoSmithKline, LLC.$12,865Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-07-02Abbott Laboratories$625Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-06-24Sterilmed, Inc.$7Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-06-18Sterilmed, Inc.$274Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-06-18Sterilmed, Inc.$29Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-06-17PFIZER INC.$47Research paymentIn-kind items and servicesA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-06-09Novartis Pharmaceuticals Corporation$15,376Research paymentCash or cash equivalentA RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL ASSESSING THE IMPACT OF LIPOPROTEIN (A) LOWERING WITH T2020
2020-06-04CSL Behring$837Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-05-27PFIZER INC.$12,540Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-05-27GlaxoSmithKline, LLC.$5,914Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-05-27PFIZER INC.$3,200Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-05-27PFIZER INC.$1,846Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-05-27PFIZER INC.$1,600Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-05-27PFIZER INC.$601Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-05-26Kowa Research Institute, Inc.$2,092Research paymentCash or cash equivalent DrugK-877-3022020
2020-05-18Boston Scientific Corporation$599Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-05-14CSL Behring$706Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-05-12Kowa Research Institute, Inc.$223Research paymentCash or cash equivalent DrugK-877-3022020
2020-05-11American Regent$170Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-05-06Kowa Research Institute, Inc.$376Research paymentCash or cash equivalent DrugK-877-3022020
2020-05-04Boston Scientific Corporation$1,658Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-05-04Boston Scientific Corporation$200Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-04-28GlaxoSmithKline, LLC.$20,893Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-04-27Kowa Research Institute, Inc.$448Research paymentCash or cash equivalent DrugK-877-3022020
2020-04-27CSL Behring$82Research paymentIn-kind items and servicesA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-04-20Boston Scientific Corporation$440Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-04-14CSL Behring$250Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-04-09CSL Behring$5,142Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-04-08American Regent$4,642Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-04-06GlaxoSmithKline, LLC.$10,969Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-03-25Sterilmed, Inc.$63Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-03-24GlaxoSmithKline, LLC.$73,515Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-03-18Kowa Research Institute, Inc.$8,576Research paymentCash or cash equivalent DrugK-877-3022020
2020-03-18Olympus America Inc.$84GiftIn-kind items and servicesOlympus GI Accessories Device, EndoTherapy Products2020
2020-03-16GlaxoSmithKline, LLC.$6,258Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-03-12CSL Behring$5,810Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-03-12Abbott Laboratories$700Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-03-12CSL Behring$200Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2020
2020-03-09American Regent$500Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-03-04GE HEALTHCARE$3,023Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-03-02Boston Scientific Corporation$6,024Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTASAP TOO2020
2020-03-02Zimmer Biomet Holdings, Inc.$12Food and BeverageIn-kind items and servicesSternaLock Blu Device, CMF & Thoracic2020
2020-02-24GlaxoSmithKline, LLC.$83,901Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA2020
2020-02-21Kowa Research Institute, Inc.$6,565Research paymentCash or cash equivalent DrugK-877-3022020
2020-02-18Boston Scientific Corporation$635Research paymentCash or cash equivalentACUITY Device, TACHYNAVIGATE X4 STUDY2020
2020-02-18Boston Scientific Corporation$440Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-02-05Sterilmed, Inc.$91Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-01-31Amgen Inc.$23,585Research paymentCash or cash equivalentRepatha Biological, CardiologyFOURIER OLE (Ph 4)2020
2020-01-30Amgen Inc.$12,350Research paymentCash or cash equivalentNeulasta Biological, OncologyProspective Observational Study of Onpro vs SOC.2020
2020-01-28E.R. Squibb & Sons, L.L.C.$550Research paymentCash or cash equivalentOPDIVO Biological, OncologyA US Multi-Site Observational Study in Patients With Unresectable And Metastatic Melanoma: The OPTIMIzE Study2020
2020-01-28Eli Lilly and Company$358Research paymentIn-kind items and servicesA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2020
2020-01-27Novartis Pharmaceuticals Corporation$136,084Research paymentCash or cash equivalentENTRESTO Drug, CARDIOVASCULARPROSPECTIVE COMPARISON OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR ARNI VERSUS ACE INHIBITOR TRIAL TO DETERMINE IMPACT 2020
2020-01-21Kowa Research Institute, Inc.$10,325Research paymentCash or cash equivalent DrugK-877-3022020
2020-01-21Boston Scientific Corporation$200Research paymentCash or cash equivalentCLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCTSFA DES PIVOTAL2020
2020-01-17Sterilmed, Inc.$13Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2020
2020-01-16AstraZeneca Pharmaceuticals LP$10,098Research paymentCash or cash equivalentStudy of 1st Line Therapy Study of MEDI4736 With Tremelimumab Versus SoC in Non Small Cell Lung Cancer NSCLC NEPTUNE2020
2020-01-16PFIZER INC.$221Research paymentCash or cash equivalentA PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOST2020
2020-01-13American Regent$11,836Research paymentCash or cash equivalentINJECTAFER Drug, AnemiaHeart_FID2020
2020-01-13Abbott Laboratories$700Research paymentCash or cash equivalentABSORB Device, VascularABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)2020
2020-01-10Amgen Inc.$101,128Research paymentIn-kind items and servicesRepatha Biological, CardiologyFOURIER OLE (Ph 4)2020
2020-01-07Eli Lilly and Company$46,410Research paymentCash or cash equivalentA RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD2020

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Stark CountyCanton city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Canton, OH, county Stark County, OH, state Ohio; placed by its city name.

MeasurePlace (city or town)
Canton, OH
County
Stark County, OH
State
Ohio
Population B0100369,755373,71311,810,293
Population, 2020 census P170,872374,85311,799,448
Median age B0100235.241.839.7
Under 18 B0100125.4%21.5%22.0%
65 and over B0100115.7%20.5%18.3%
Households B1100129,302155,9554,863,191
Foreign born B050022.5%2.2%5.2%
Median household income B19013$43,188$67,934$71,389
Median family income B19113$53,992$86,156$92,749
Per capita income B19301$24,690$36,762$40,552
Poverty rate B1700127.4%12.5%13.3%
Unemployment rate B230257.8%3.9%4.8%
Civilian labor force B2302532,390186,7135,994,779
Mean commute (minutes) B0801319.121.723.4
Bachelor's degree or higher B1500316.4%25.9%31.5%
Housing units B2500133,836167,9495,292,391
Owner-occupied B2500348.7%69.2%67.2%
Renters B2500351.3%30.8%32.8%
Median home value B25077$97,800$186,400$214,800
Median gross rent B25064$850$909$1,034
White, not Hispanic B0300259.0%83.8%75.8%
Black B0300223.4%7.1%12.0%
Hispanic or Latino B030026.7%3.0%4.8%
Asian B030020.6%0.9%2.5%
American Indian and Alaska Native B030020.0%0.1%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Canton, OH.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.